Health ❯Healthcare ❯Cancer ❯Treatment

Targeted Therapy

Chemotherapy-Free Regimen Shows 94% Progression-Free Survival in CLL Trial

Five-year data show a targeted regimen of ibrutinib plus venetoclax outperforms standard therapies in chronic lymphocytic leukaemia

NHS England First Worldwide to Roll Out 'Trojan Horse' Myeloma Therapy

NHS England rolls out world-first liquid biopsy to fast-track cancer treatment